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Background: Cerebral autosomal dominant arteriopathy
with subcortical infarcts and leucoencephalopathy
(CADASIL) is a cause of hereditary cerebrovascular disease.
It results from mutations in the Notch3 gene, a large gene
with 33 exons. A cluster of mutations around exons 3 and 4
was originally reported and limited scanning of these exons
was suggested for the diagnosis in most cases.
Objective: To report Notch3 mutation analysis in 28
unrelated Italian CADASIL families from central and south
Italy.
Results: The highest rate of mutations was found in exon 11
(21%) and only 18% of mutations were in exon 4. This may
be related to the peculiar distribution of Notch3 mutations in
the regions of origin of the families.
Conclusions: The results suggest that limited scanning of
exons 3 and 4 is inadvisable in CADASIL cases of Italian
origin.
C
erebral autosomal dominant arteriopathy with subcor-
tical infarcts and leucoencephalopathy (CADASIL) is
now recognised to be a cause of hereditary cerebrovas-
cular disease. It results from mutations in Notch3, a gene
encoding a transmembrane protein involved in cell signalling
and cell differentiation.1 All the mutations described up to
now result in a gain or loss of one cysteine residue in one of
34 epidermal growth factor-like repeats. The clinical spec-
trum of the disease is broad, even in the same family. The
most frequent manifestations include one or more of the
following: recurrent ischaemic episodes (transient ischaemic
attacks or stroke), migraine with aura, cognitive decline, and
psychiatric changes.2 The white matter abnormalities
detected by magnetic resonance imaging (MRI) are strongly
suggestive3 but often indistinguishable from other neurolo-
gical disorders such as multiple sclerosis, lacunar stroke with
leukoaraiosis, and adult onset leucoencephalopathies. This
makes the clinical diagnosis of CADASIL difficult and implies
that it may be underestimated in the wider population with
MRI evidence of diffuse white matter abnormalities.
The hallmark of the disease is the presence of deposits of
granular osmiophilic material (GOM) in the small vessels.
Electron microscopic screening of skin arterioles for GOM
was the first diagnostic method proposed but it is not
sufficiently sensitive (up to 50% false negatives (Markus et al4
and our own unpublished data). Diagnosis of CADASIL is
therefore confirmed by demonstration of mutations in the
Notch3 gene. Complete Notch3 gene mutation analysis is
expensive and time consuming because of the large number
of exons, and it is therefore unsuitable for routine diagnosis.
Although CADASIL has a broad mutational spectrum,5
clustering of mutations around exon 3 and especially exon
4 was originally reported in about 70% of cases6 and it was
subsequently suggested that scanning should be limited to
these exons for quick identification of suspected cases.5
However, further studies of the spectrum of Notch3 gene
mutations in a geographically localised population revealed
significant divergence from this pattern and suggested the
need to examine additional exons (numbers 5, 6, 11, and
18),4 6 7 largely dependent on the population screened. Here
we describe the mutation pattern of the Notch3 gene in 28
Italian families with CADASIL from central and southern
Italy.
METHODS
Notch3 gene mutation screening of exons 2 to 23 (starting
with exons 4 and 3) by denaturing high performance liquid
chromatography (DHPLC) followed by direct sequencing was
carried out in 28 new index cases, belonging to unrelated
consecutively diagnosed families from central (13 cases) and
southern Italy (15 cases), with clinical and MRI diagnosis of
CADASIL. Informed consent was obtained in all cases. The
analysis was carried on in two laboratories, Siena and Piano
Lago di Mangone (Cosenza), which are the referral centres in
central and southern Italy, respectively, for the diagnosis of
CADASIL, in the framework of the Italian CADASIL group.
The prevalence of mutations in different exons was deter-
mined and the relation to geographical origin analysed.
Genomic DNA was extracted from buffy coat previously
prepared from peripheral blood. Polymerase chain reaction
(PCR) was undertaken with primers (comprising intron–
exon boundaries) specific for exons of the Notch3 gene. PCR
reactions were carried out in 50 ml reaction volumes
containing 130 ng genomic DNA, 20 pmol forward and
reverse primers, 0.2 mM dNTPs, 2U DNA polymerase
(Optimase, Transgenomic, Crewe, UK), 1.5 mM MgSO4,
and 16Optimase buffer using a DNA thermal cycler (model
9600; Perkin Elmer, Foster City, California, USA). The
mixtures were amplified as recommended by the Optimase
protocol with annealing temperature for each primer couple.
PCR products were analysed by DHPLC using the Wave
system (Transgenomic Inc, Omaha, Nebraska, USA). When a
variant pattern was detected by DHPLC, the sample was
sequenced using the ABI Prism Big Dye Terminator cycle
sequencing ready reaction kit (Perkin Elmer).
RESULTS
Eighteen different mutation sites were detected in the 28
index cases, and seven novel mutations were identified: one
deletion in each of exons 38 and 49 and five missense
mutations (three in exon 8 and one in each of exons 6 and
10) (table 1).
Abbreviations: CADASIL, cerebral autosomal dominant arteriopathy
with subcortical infarcts and leucoencephalopathy; DHPLC, denaturing




Five families had mutations in exon 4 (17.8%) and exon 3
(17.8%), six families in exon 11 (21.4%), four families in
exon 8 (14.3%), three families in exon 6 (10.7%), two families
in exon 19 (7.1%), and one family each in exons 10, 20, and
22 (3.6%). All families with mutation in exon 4 (five of five)
and the most of those with mutation in exon 11 (four of six)
were from central Italy. Otherwise, mutations in exon 3 (five
of five) and exon 8 (four of four) were detected only in
families from southern Italy. All cases with involvement of
exon 11 carried the same C1897T mutation.
DISCUSSION
This is the first mutation spectrum analysis in a significant
number of unrelated Italian families with CADASIL.
Surprisingly, contrary to previous reports in different series
of patients,4–7 10 exon 4 was not the most common site of
mutation, the proportion being less than 18%. Taken
together, mutations in exon 4 and 3 accounted for only
36% of CADASIL cases, less than half the figure reported in
the original French series6 and, more recently, in the British
one.4 On the other hand, mutations in exon 11, the most
common in our analysis, were not found in any of the 48
British cases4 and were rarely found in other less homo-
geneous series.5–7 We also detected a substantial number of
mutations in exon 8 (14%) and exon 6 (11%). Moreover, the
geographical distribution of some mutations is noteworthy:
exon 4 mutations were only found in families from central
Italy, whereas mutations in exons 3 and 8 they were detected
only in families from the south.
To our knowledge, only a few Italian CADASIL families
have been reported. Mutations were found in exon 411–13 and
in exon 6.14
In all but two cases, the present analysis showed missense
mutations, five of which were novel: three in exon 8 and one
each in exons 6 and 10 (table 1). No mutation has previously
been reported in exon 10. Interestingly, the same C1897T
mutation involved exon 11 in all cases (six of six),
irrespective of geographical origin. The recurrence of this
rare mutation in six apparently unrelated families is striking.
However, a founder effect cannot be ruled out. Cases 5 and 10
(table 1) carried two novel deletions in the Notch3 gene8 9
adding to the few (only four) mutations of this type already
reported.5 The deletion on exon 3 did not involve a cysteine
residue.8
CADASIL is an increasingly recognised hereditary cerebro-
vascular pathology leading to progressive neurological handi-
cap. The wide variability in clinical presentation and
evolution, the apparent absence of inheritance in many
cases, and the substantially non-specific pattern of MRI
lesions, at least in the early stages, make clinical diagnosis
difficult. The problem of diagnostic screening is a crucial
point and the subject of international debate. That the
disease is not only underestimated but also occurs worldwide
has become evident since genetic testing became widely
available. The peculiar distribution of Notch3 gene mutations
emerging from the first population studies suggests that a
different mutation analysis approach is needed from country
to country, and as the present findings intimate, perhaps also
in different parts of the same country.
Our results strongly suggest that the spectrum of CADASIL
mutations should be analysed in different populations and
that the regional origin of families should be taken into
account in planning the expensive and time consuming
molecular screening protocol. In Italy scanning limited to
exons 3 and 4 would have confirmed the diagnosis in only
one third of cases.
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Table 1 The spectrum of Notch3 mutations found in 28 Italian families
Family Origin Exon Mutation site Amino acid change
Proportion
with exon
1 South 3 C406T Arg110Cys 17.8%
2 South 3 C406T Arg110Cys
3 South 3 C346T Arg90Cys
4 South 3 C346T Arg90Cys
5 South 3 Deletion from C341
to G352*
Deletion of 4 aa from Ala88
to Gly91
6 Central 4 C499T Arg141Cys 17.8%
7 Central 4 T625A Cys183Ser
8 Central 4 C697T Arg207Cys
9 Central 4 C697T Arg207Cys
10 Central 4 Deletion from T312
to G316*
Frame shift aa 125–158 Stop
codon aa 159
11 South 6 C1072T Arg322Cys 10.7%
12 South 6 C1072T Arg322Cys
13 Central 6 T1090C* Cys338Arg
14 South 8 G1361A* Cys428Tyr 14.3%
15 South 8 T1360C* Cys428Arg
16 South 8 T1396A* Cys440Ser
17 South 8 C1423T Arg449Cys
18 South 10 G1660T* Gly528Cys 3.6%
19 Central 11 C1897T Arg607Cys 21.4%
20 Central 11 C1897T Arg607Cys
21 Central 11 C1897T Arg607Cys
22 Central 11 C1897T Arg607Cys
23 South 11 C1897T Arg607Cys
24 South 11 C1897T Arg607Cys
25 Central 19 C3094T Arg1006Cys 7.1%
26 Central 19 C3094T Arg1006Cys
27 Central 20 C3304T Arg1076Cys 3.6%
28 South 22 C3769T Arg1231Cys 3.6%
*New mutation.
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